MIRACLE Medical Technology Act of 2025
Latest action · Jan 23, 2025 Referred to the House Committee on Energy and Commerce.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJan 23, 2025
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025 or the MIRACLE Medical Technology Act of 2025
This bill requires the Department of Health and Human Services (HHS) to implement a program for the United States and Israel to collaborate on developing and delivering health care products and services. The program must include coordinated activities in specified areas, including research and development, use of innovative technology, intellectual property protection, regulatory harmonization, disease prevention, and biological product manufacturing. The bill authorizes HHS to establish a joint United States-Israel Health Care Collaboration Center in the United States to leverage existing expertise for advancing the program’s purposes.
Cosponsors 3
Members who signed on, in the order they did. Signatures ran from Jan 23, 2025 to Dec 23, 2025; 2 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-FL | Darren Soto | Original | Jan 23, 2025 |
| R-IA | Mariannette Miller-Meeks | Original | Jan 23, 2025 |
| D-NY | Thomas R. Suozzi | Dec 23, 2025 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Jan 23, 2025 |
Actions 2
Everything that happened, newest first.
- Jan 23, 2025Introduced in House
- Jan 23, 2025Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 171, no. 14, January 23, 2025, page H388.
Titles 3
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To require the Secretary of Health and Human Services, in consultation with the Secretary of Commerce, the Council for Technology and Innovation of the Centers for Medicare & Medicaid Services, and the Commissioner of Food and Drugs, to carry out a program to facilitate and coordinate efforts between the United States and Israel to expand and enhance collaboration on the development and delivery of health care products and services.
- Short Title(s) as Introduced
- MIRACLE Medical Technology Act of 2025
- Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Advanced technology and technological innovations
- Advisory bodies
- Data collection, sharing, protection
- Diplomacy, foreign officials, Americans abroad
- Employment and training programs
- Health
- Health promotion and preventive care
- Health technology, devices, supplies
- Intellectual property
- Israel
- Manufacturing
- Medical research
- Prescription drugs
- Public-private cooperation
- Supply chain
Text 1
Each version as it was printed, newest first.
- Jan 23, 2025Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.